Basics Castle Biosciences, Inc. IPO Date: July 22, 2019 Sector: Healthcare Market Cap: $683.44M Activated in VL: True Average Daily Range Avg Daily Range: $1.01 | 3.02% Avg Daily Range (30 D): $0.47 | 2.38% Avg Daily Range (90 D): $0.40 | 2.12% Institutional Daily Volume Avg Daily Volume: .25M Avg Daily Volume (30 D): .51M Avg Daily Volume (90 D): .41M Trade Size Avg Trade Size (Sh.): 57 Avg Trade Size (Sh.) (30 D): 58 Avg Trade Size (Sh.) (90 D): 54 Institutional Trades Total Inst.Trades: 1,269 Avg Inst. Trade: $1.29M Avg Inst. Trade (30 D): $1.51M Avg Inst. Trade (90 D): $1.35M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.38M Avg Closing Trade (30 D): $1.35M Avg Closing Trade (90 D): $1.29M Avg Closing Volume: 45.32K     News Aug 28, 2025 @ 2:44 PM FDA Tightens Survival Standards as Cancer Drug Pip... Source: Prnewswire Jul 29, 2025 @ 11:00 AM Castle Biosciences to Present at the Canaccord Gen... Source: Castle Biosciences Inc. Jul 25, 2025 @ 11:00 AM Castle Biosciences’ Founder, President and ... Source: Derek Maetzold Jul 23, 2025 @ 11:00 AM FDA Grants Breakthrough Device Designation to Cast... Source: Castle Biosciences Inc. Jul 17, 2025 @ 11:00 AM Castle Biosciences Honored with Multiple Top Workp... Source: Castle Biosciences Financials   TTM Q1 2025 Q3 2024 Basic EPS $.16 $-.9 $.08 Diluted EPS $.15 $-.9 $.08 Revenue $ 86.19M $ 87.99M $ 85.78M Gross Profit $ 68.56M $ 71.61M $ 70.17M Net Income / Loss $ 4.52M $ -25.85M $ 2.27M Operating Income / Loss $ -4.25M $ -27.93M $ 5.08M Cost of Revenue $ 17.63M $ 16.38M $ 15.61M Net Cash Flow $ -7.46M $ -30.02M $ 9.39M PE Ratio 157.07